Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

AbbVie Inc. ABBV

Healthcare  —  Drug Manufacturers General
264.34 (0.78) (0.29%) as of 25 Sep
Market cap
$467.4B
P/E
74.7×
S&P 500 Member Dividend Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

AbbVie Inc. (ABBV) EV/EBITDA

As of 25 September 2026, AbbVie Inc. (ABBV) trades at a EV/EBITDA of 20.8×. Over the past ten years it has ranged from 8.2× (March 2020) to 28.7× (July 2015); the current reading is higher than 92% of that period. That is above the Drug Manufacturers General industry median of 13.9× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 19.4× 13.45%
FY2024 17.1× 33.36%
FY2023 12.8× (0.28%)
FY2022 12.9× 10.87%
FY2021 11.6× (19.32%)
FY2020 14.4× 36.44%
FY2019 10.5× (50.78%)
FY2018 21.4× 27.98%
FY2017 16.7× 33.69%
FY2016 12.5× (12.41%)

Quarterly

Period EV/EBITDA Change
Jun 2026 19.9× 7.51%
Mar 2026 18.5× (4.48%)
Dec 2025 19.4× (7.23%)
Sep 2025 20.9× 26.36%
42 more quarters

Against its own ten years

Low 8.2× High 28.7×
Ten-year median 14.2×
Current reading's percentile 92

EV/EBITDA against peers

Company EV/EBITDA
PFE Pfizer Inc. compare 10.5×
AZN AstraZeneca PLC compare 13.9×
NVS Novartis AG compare 14.0×
AMGN Amgen Inc. compare 16.2×
JNJ Johnson & Johnson compare 19.2×
ABBV AbbVie Inc. 20.8×
MRK Merck & Co., Inc. compare 30.0×
LLY Eli Lilly and Company compare 30.8×
GILD Gilead Sciences, Inc. compare 804×
Drug Manufacturers General industry median 13.9×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ABBV